Not applicableWithdrawnNCT04035408What this trial is testingFacial Skin Health Tracking Feasibility in Breast Cancer PatientsWho this might be right forBreast Cancer Female University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT00259090What this trial is testingAnti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast CancerWho this might be right forBreast Cancer AstraZeneca 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT02238808What this trial is testingSee Whether Estrogen Can Slow the Growth of Some ER Positive Breast CancersWho this might be right forEstrogen Receptor Positive Breast Cancer AHS Cancer Control Alberta 19
Early research (Phase 1)Study completedNCT01840488What this trial is testingBN83495 Phase I in Post-menopausal WomenWho this might be right forBreast Cancer Ipsen 50
Not applicableStudy completedNCT05012644What this trial is testingComparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor AloneWho this might be right forMetastatic Breast Cancer Pfizer 197
Large-scale testing (Phase 3)Study completedNCT01712893What this trial is testingSimultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast CancerWho this might be right forBreast Cancer Fudan University 216
Not applicableActive Not RecruitingNCT05474391What this trial is testingMammaPrint Value for Pre-menopausal Breast Cancer PatientsWho this might be right forBreast Cancer Fudan University 200
Not applicableEnded earlyNCT00352872What this trial is testingPharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast CancerWho this might be right forBreast Cancer Indiana University School of Medicine 23
Early research (Phase 1)Study completedNCT02058381What this trial is testingA Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast CancerWho this might be right forPre-menopausal Breast CancerPI3K Pathway Inhibition Novartis Pharmaceuticals 40
Not applicableLooking for participantsNCT06904365What this trial is testingOvarian-Sparing Adaptive Radiotherapy in Young Adult WomenWho this might be right forUterine CancerRectal CancerColon Cancer+9 more Washington University School of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT00303524What this trial is testingComparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal PatientsWho this might be right forBreast Cancer AstraZeneca 170
Not applicableStudy completedNCT01461070What this trial is testingIntestine Bacteria and Breast Cancer RiskWho this might be right forBreast Neoplasms National Cancer Institute (NCI) 175
Not applicableStudy completedNCT01385280What this trial is testingPilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Cancer+2 more University of Arizona 13
Testing effectiveness (Phase 2)Study completedNCT00322348What this trial is testingStudy of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal WomenWho this might be right forAdvanced Breast Cancer AstraZeneca 98
Large-scale testing (Phase 3)Study completedNCT00232661What this trial is testingPROACT - Pre-Operative Arimidex Compared To TamoxifenWho this might be right forBreast Cancer AstraZeneca 452
Large-scale testing (Phase 3)Study completedNCT02816125What this trial is testingEffects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal WomenWho this might be right forHealthyPremenopausal Period University of Guelph 56
Not applicableStudy completedNCT05122377What this trial is testingRWE About QOL and Compliance of Patients With OFS in ChinaWho this might be right forBreast CancerQuality of LifeHormone Receptor-positive Breast Cancer Fudan University 562
Not applicableStudy completedNCT00188682What this trial is testingBreast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.Who this might be right forBreast Cancer University Health Network, Toronto 300
Testing effectiveness (Phase 2)Study completedNCT05549505What this trial is testingA Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryWho this might be right forBreast Cancer Arvinas Inc. 152
Testing effectiveness (Phase 2)WithdrawnNCT01814865What this trial is testingAnti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast CancerWho this might be right forPost-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer British Columbia Cancer Agency